NO924372L - Anordning for kontrollert avgivelse - Google Patents

Anordning for kontrollert avgivelse

Info

Publication number
NO924372L
NO924372L NO92924372A NO924372A NO924372L NO 924372 L NO924372 L NO 924372L NO 92924372 A NO92924372 A NO 92924372A NO 924372 A NO924372 A NO 924372A NO 924372 L NO924372 L NO 924372L
Authority
NO
Norway
Prior art keywords
active substance
core
reading
exposed
fluid medium
Prior art date
Application number
NO92924372A
Other languages
English (en)
Norwegian (no)
Other versions
NO924372D0 (no
Inventor
Sham Kumar Chopra
Avinash Kumar Nangia
David Lee
Thomas Patrick Molloy
Original Assignee
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919124106A external-priority patent/GB9124106D0/en
Priority claimed from GB919124108A external-priority patent/GB9124108D0/en
Priority claimed from GB929205463A external-priority patent/GB9205463D0/en
Application filed by Glaxo Canada filed Critical Glaxo Canada
Publication of NO924372D0 publication Critical patent/NO924372D0/no
Publication of NO924372L publication Critical patent/NO924372L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Molding Of Porous Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Container, Conveyance, Adherence, Positioning, Of Wafer (AREA)
  • Seal Device For Vehicle (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
NO92924372A 1991-11-13 1992-11-12 Anordning for kontrollert avgivelse NO924372L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919124106A GB9124106D0 (en) 1991-11-13 1991-11-13 Device
GB919124108A GB9124108D0 (en) 1991-11-13 1991-11-13 Device
GB929205463A GB9205463D0 (en) 1992-03-12 1992-03-12 Device

Publications (2)

Publication Number Publication Date
NO924372D0 NO924372D0 (no) 1992-11-12
NO924372L true NO924372L (no) 1993-05-14

Family

ID=27265924

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924372A NO924372L (no) 1991-11-13 1992-11-12 Anordning for kontrollert avgivelse

Country Status (15)

Country Link
US (1) US5342627A (esLanguage)
EP (1) EP0542364B1 (esLanguage)
JP (2) JP3768247B2 (esLanguage)
AT (1) ATE133331T1 (esLanguage)
AU (1) AU658942B2 (esLanguage)
CA (1) CA2082740C (esLanguage)
CZ (1) CZ337392A3 (esLanguage)
DE (1) DE69207863T2 (esLanguage)
DK (1) DK0542364T3 (esLanguage)
ES (1) ES2083074T3 (esLanguage)
GR (1) GR3019431T3 (esLanguage)
IL (1) IL103723A0 (esLanguage)
NO (1) NO924372L (esLanguage)
NZ (1) NZ245100A (esLanguage)
TW (1) TW262387B (esLanguage)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5398850A (en) 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4431653C2 (de) 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5700245A (en) 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
EP1095650A1 (en) * 1999-10-29 2001-05-02 Universiteit Leiden Double phase time-controlled release system
US6569152B2 (en) 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ATE307591T1 (de) * 2000-12-14 2005-11-15 Ortho Mcneil Pharm Inc Zubereitungen enthaltend ein steroidhormon und ein stabilisierungsmittel in nicht-kristalliner form
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
MXPA04004665A (es) 2001-11-14 2004-09-10 Alza Corp Composiciones de deposito inyectable y uso de los mismos.
NZ533435A (en) * 2001-11-14 2007-10-26 Alza Corp Injectable depot compositions and uses thereof
USD481456S1 (en) 2002-01-30 2003-10-28 Smithkline Beecham P.L.C. Capsule
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
KR100882707B1 (ko) * 2002-07-29 2009-02-06 글락소 그룹 리미티드 라모트리진을 포함하는 서방형 제제
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
NZ537955A (en) * 2002-07-31 2007-10-26 Alza Corp Injectable depot compositions and uses thereof
AU2003256849A1 (en) * 2002-07-31 2004-02-16 Alza Corporation Injectable multimodal polymer depot compositions and uses thereof
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
AU2005325213B2 (en) 2004-08-04 2010-10-07 Evonik Operations Gmbh Methods for manufacturing delivery devices and devices thereof
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
ATE489079T1 (de) 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
WO2010017821A1 (en) * 2008-08-14 2010-02-18 Daniel Bar-Shalom Coated tablets with a remaining degradation surface over the time8
CA2753416A1 (en) * 2009-02-23 2010-08-26 Gopi Venkatesh Controlled release compositions comprising anti-cholinergic drugs
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110136815A1 (en) * 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US20110223244A1 (en) * 2010-03-09 2011-09-15 Elan Pharma International Limited Alcohol resistant enteric pharmaceutical compositions
US9233076B2 (en) 2010-12-13 2016-01-12 Purdue Pharma L.P. Controlled release dosage forms
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
EP3132246A4 (en) * 2014-04-14 2017-12-13 Abbott Molecular Inc. Medium used for blood sample collection and transport
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US12163326B1 (en) * 2019-10-01 2024-12-10 NeverClog, LLC System for capturing and destroying hair or waste within a commercial shower drain
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
US12383246B2 (en) 2020-10-12 2025-08-12 Abbott Cardiovascular Systems, Inc. Vessel closure device with improved safety and tract hemostasis
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US480076A (en) * 1892-08-02 Thomas p
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance

Also Published As

Publication number Publication date
JP4166716B2 (ja) 2008-10-15
NZ245100A (en) 1995-06-27
EP0542364B1 (en) 1996-01-24
ATE133331T1 (de) 1996-02-15
AU658942B2 (en) 1995-05-04
JP3768247B2 (ja) 2006-04-19
CA2082740A1 (en) 1993-05-14
AU2827292A (en) 1993-05-20
EP0542364A1 (en) 1993-05-19
DK0542364T3 (da) 1996-03-11
GR3019431T3 (en) 1996-06-30
US5342627A (en) 1994-08-30
ES2083074T3 (es) 1996-04-01
TW262387B (esLanguage) 1995-11-11
DE69207863D1 (de) 1996-03-07
JP2004189754A (ja) 2004-07-08
CZ337392A3 (en) 1993-10-13
NO924372D0 (no) 1992-11-12
CA2082740C (en) 2003-10-14
IL103723A0 (en) 1993-04-04
JPH05262640A (ja) 1993-10-12
DE69207863T2 (de) 1996-06-05

Similar Documents

Publication Publication Date Title
NO924372L (no) Anordning for kontrollert avgivelse
Lee et al. Role of myocardial catecholamines in cardiac contractility
Wang et al. Quorum sensing regulatory cascades control Vibrio fluvialis pathogenesis
ES269281U (es) Distribuidor de pastillas.
FR76385E (fr) Valve de purge pour le desserrage des freins automatiques à fluide sous pression
GOLDFISCHER et al. Peroxidase activity in peroxisomes (microbodies) of acatalasemic mice
Lee et al. Rac1 regulates heat shock responses by reorganization of vimentin filaments: identification using MALDI-TOF MS
Suzue et al. Carotenogenesis and resistance of Micrococcus pyogenes to tetracyclines
Mori et al. Differential responses of endogenous adult mouse neural precursors to excess neuronal excitation
MY106930A (en) Controlled release device
FR1292097A (fr) Dispositif de commande des freins à mâchoires à l'aide d'un fluide sous pression
Faust Parasiticidal Potencies of the Tri-to Hepta-Methyl Derivatives of Rosanilin.
MX2021002686A (es) Formulacion controlada de liberacion de farmacos.
NO159448C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt n-(2-(((5-dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioksybenzyl)-2-nitro-1,1-etendiamin.
Holder et al. The effect of rations on vitelline membrane strength
FR1115589A (fr) Distributeur pour fluide sous pression et ses applications, en particulier à la commande d'embrayages
Spasskii et al. Character of Interrelations Between Chironomidae and Their Parasites, Mermithidae,(In Russian)
FR1166732A (fr) Robinet d'arrêt, notamment pour fluide à haute pression
SU566656A1 (ru) Устройство дл штамповки
Halimie et al. Feeding and the uptake of phosphamidon by two strains of Myzus persicae (Sulz.) on radish plants
BE590683R (fr) Valve de purge pour le desserrage des freins automatiques à fluide sous pression
FR67791E (fr) Distributeur pour fluide sous pression et ses applications, en particulier à la commande d'embrayages
Archer et al. Myocardial Failure with Altered Response to Epinephrine in Endotoxin Shock.
Tyus Spawning of rock bass in North Carolina during 1968
Murray et al. Considerations involved in the standardization of polyvalent respiratory vaccines